Hormone Replacement Therapy Market Analysis | CMI

1

• Coherent Market Insights
• Market Research and Business Consulting Services
• https//www.coherentmarketinsights.com/
• COVID-19 Impact Tracker

2
HORMONE REPLACEMENT THERAPY MARKET ANALYSIS

• Hormone Replacement Therapy Market, by Therapy
  Type (Estrogen Replacement Therapy, Human Growth
  Hormone (HGH) Replacement Therapy, Thyroid
  Replacement Therapy, and Testosterone Replacement
  Therapy), by Route of Administration (Oral,
  Parenteral, and Others), by Application
  (Hypothyroidism, Male Hypogonadism, Growth
  Hormone Deficiency, Menopause, and Others), by
  Distribution Channel (Hospital Pharmacies, Retail
  Pharmacies, and Online Pharmacies), and by Region
  (North America, Latin America, Europe, Asia
  Pacific, Middle East, and Africa) - Size, Share,
  Trends, and Forecast to 2026
• The global hormone replacement therapy market
  size was valued at US 10.58 billion in 2017 and
  is expected to witness a CAGR of 5.2 over the
  forecast period (2018 2026).

3
Global Hormone Replacement Therapy Market Share
() Analysis, By Therapy Type 2017
4
Market Drivers

• Increasing prevalence of various chronic
  conditions are expected to drive growth of the
  Hormone Replacement Therapy Market
• Increasing prevalence of hypogonadism in adult
  men worldwide is expected to drive growth of the
  hormone replacement therapy market.
• According to the European Association of Urology
  2016 report, in middle-aged men, the incidence of
  hypogonadism varies from 2.1 to 12.8. The
  incidence of low testosterone and symptoms of
  hypogonadism in men aged 40-79 varies form 2.1
  to 5.7, in Europe.
• Ease in access and government support for
  research and development activities is expected
  to aid in growth of the hormone replacement
  therapy market. Financial help by NGOs such as
  the National Gaucher Society help patients
  receive enzyme replacement therapy that are
  costly.

5
Hormone Replacement Therapy Market Restraints

• Stringent regulations proposed by the U.S. Food
  and Drug Administration (FDA) regarding the
  application of hormone replacement products,
  owing to increasing risk of adverse
  cardiovascular diseases is expected to hamper
  growth of the hormone replacement therapy market
  over the forecast period.
• In February 2018, the U.S. FDA updated policies
  and stated that testosterone replacement product
  manufacturers need to change the labelling to
  inform the patients about possible increased risk
  of heart attack and stroke.
• Furthermore, in January 2018 committee meeting,
  the FDA proposed the regulation demanding
  testosterone manufacturers to conduct a
  post-marketing randomized, double-blind,
  placebo-controlled trial, before marketing the
  product to determine whether this therapy
  increases major adverse cardiovascular diseases
  such as myocardial infarction and stroke or not.

6
Hormone Replacement Therapy Market - Regional
Insights

• On the basis of region, the global hormone
  replacement therapy market is segmented into
  North America, Latin America, Europe, Asia
  Pacific, Middle East, and Africa. North America
  is expected to hold dominant position in the
  global hormone replacement therapy market, owing
  to continuous launch of various generic products
  for hormone replacement therapies by
  manufacturers.
• Furthermore, Europe is expected to be the second
  largest contributor to the hormone replacement
  therapy market, in terms of revenue and is
  expected to gain significant traction in the near
  future. This is owing to launch of new drugs and
  therapies to combat secondary hyperparathyroidism
  and presence of significant population suffering
  from the disease in this region.
• For instance, in December 2016, Amgens drug
  etecalcetide (Parsabiv) received marketing
  approval in Europe by the European Commission for
  the treatment of secondary hyperparathyroidism in
  adult patients with chronic kidney diseases.

7

• Asia Pacific is expected to witness fastest
  growth over the forecast period, owing to
  increasing healthcare associated issues with
  rising incidence of chronic diseases, high
  prevalence of hypogonadism in men with type II
  diabetes mellitus, and rising prevalence of
  diabetes population in this region.
• For instance, according to the International
  Diabetes Federation (IDF) Diabetes Atlas 2017,
  number of people suffering from diabetes aged
  between 20 to 79 years in South East Asia region
  and Western Pacific region in 2017, was 82
  million and 159 million, respectively.

8
Global Hormone Replacement Therapy Market Value
(US Mn) Y-o-Y Growth ()
9
Hormone Replacement Therapy Market - Competitive
Landscape

• Manufacturers are focusing on developing generic
  versions of various drugs for the treatment of
  certain disorders that are highly prevalent in
  women such as hypothyroidism. For instance, Teva
  Pharmaceutical Industries Ltd. launched generic
  version of Vagifem (estradiol vaginal inserts),
  10 mcg in the U.S. on 24, July 2017. Estradiol
  vaginal inserts are an estrogen indicated for the
  treatment of atrophic vaginitis due to menopause.
• Moreover, on December 29, 2017, Mylan N.V. got
  the U.S. FDA approval for its Abbreviated New
  Drug Application (ANDA) for Estradiol Vaginal
  Cream USP, 0.01 and thus, the company launched
  this drug in the U.S. This cream is the first
  generic version of Allergan's Estrace Cream,
  indicated for the treatment of vulvar and vaginal
  atrophy.
• Mylan is one of the few companies that offers
  Estradiol in four delivery systems cream, gel,
  transdermal patch, and tablet. This provides
  greater benefit to healthcare professionals and
  patients, and brings long-term sustainability to
  their business.

10
Key Players

• Key players operating in the global hormone
  replacement therapy market include Novartis AG,
  Abbott Laboratories, Mylan N.V., Merck KgaA,
  Bayer AG, Pfizer Inc., Novo Nordisk A/S, QuatRx
  Pharmaceuticals, Teva Pharmaceutical Industries
  Ltd., Amgen, Inc., and Eli Lilly and Company.

11

• Request Sample Report
• Request Customization
• Download PDF Brochure
• Talk to Analyst
• Reference https//www.coherentmarketinsights.com
  /market-insight/hormone-replacement-therapy-market
  -2079

12
About Us

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions.
• What we provide
• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

13
Contact Us

• Mr. Shah
• Coherent Market Insights Pvt.Ltd.
• Address 1001 4th Ave, 3200 Seattle, WA 98154,
  U.S.
• Phone [phone]
• Email sales_at_coherentmarketinsights.com

14

• Thank You!
• Kindly follow CMI Social Media Profiles
  for the latest company updates
• Facebook
• Linkedin
• Twitter
• https//www.coherentmarketinsights.com/